Decreasing IGF-I with ageing has been shown in some studies to be associated with increased atherosclerosis and cardiovascular disease events [24–26], and it was reported that this was related to components of the metabolic syndrome [26]. This evidence concerns the gene IGF1 and metabolic syndrome.